Free Trial
LON:DOCS

Dr. Martens (DOCS) Share Price, News & Analysis

Dr. Martens logo
GBX 56.25 -1.85 (-3.18%)
As of 11:53 AM Eastern

About Dr. Martens Stock (LON:DOCS)

Key Stats

Today's Range
56.10
60.90
50-Day Range
47.98
61.05
52-Week Range
43.02
93.25
Volume
454,636 shs
Average Volume
2.30 million shs
Market Capitalization
£546.05 million
P/E Ratio
7.97
Dividend Yield
5.33%
Price Target
GBX 6,000
Consensus Rating
Hold

Company Overview

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.

Dr. Martens Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

DOCS MarketRank™: 

Dr. Martens scored higher than 56% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Dr. Martens has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Dr. Martens has only been the subject of 1 research reports in the past 90 days.

  • Read more about Dr. Martens' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Dr. Martens is 7.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.81.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Dr. Martens is 7.97, which means that it is trading at a less expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 89.50.

  • Price to Earnings Growth Ratio

    Dr. Martens has a PEG Ratio of 6.40. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Dr. Martens has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for DOCS.
  • Dividend Yield

    Dr. Martens pays a meaningful dividend of 1.36%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Dr. Martens does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Dr. Martens is 42.53%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Dr. Martens' dividend.
  • Short Interest

    There is no current short interest data available for DOCS.
  • News Sentiment

    Dr. Martens has a news sentiment score of -0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Consumer Cyclical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Dr. Martens this week, compared to 2 articles on an average week.
  • Search Interest

    23 people have searched for DOCS on MarketBeat in the last 30 days. This is an increase of 44% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £17,927.71 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    Only 4.36% of the stock of Dr. Martens is held by insiders.

  • Percentage Held by Institutions

    69.53% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Dr. Martens' insider trading history.
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

DOCS Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

DOCS Stock Analysis - Frequently Asked Questions

Dr. Martens' stock was trading at GBX 72.20 at the beginning of the year. Since then, DOCS shares have decreased by 22.1% and is now trading at GBX 56.25.
View the best growth stocks for 2025 here
.

Dr. Martens plc (LON:DOCS) released its earnings results on Thursday, November, 28th. The company reported ($1.30) earnings per share for the quarter. Dr. Martens had a trailing twelve-month return on equity of 18.91% and a net margin of 7.89%.
Read the conference call transcript
.

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Martens investors own include boohoo group (BOO), Aston Martin Lagonda Global (AML), ASOS (ASC), Vodafone Group Public (VOD), JD Sports Fashion (JD), Legal & General Group (LGEN) and Lloyds Banking Group (LLOY).

Company Calendar

Last Earnings
11/28/2024
Record date for 4/8 Dividend
3/06/2025
Ex-Dividend for 4/8 Dividend
3/06/2025
Dividend Payable
4/08/2025
Today
5/21/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Footwear & Accessories
Sub-Industry
Computer Software
Current Symbol
LON:DOCS
CIK
N/A
Fax
N/A
Employees
890
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 6,000
High Stock Price Target
GBX 6,000
Low Stock Price Target
GBX 6,000
Potential Upside/Downside
+10,566.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
7.97
Forward P/E Ratio
21.79
P/E Growth
6.4
Net Income
£68.97 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£874.20 million
Cash Flow
GBX 3.94 per share
Price / Cash Flow
14.29
Book Value
GBX 37.80 per share
Price / Book
1.49

Miscellaneous

Free Float
N/A
Market Cap
£546.05 million
Optionable
Not Optionable
Beta
0.11
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:DOCS) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners